We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

29 hedge funds and large institutions have $522M invested in Sinovac Biotech, Ltd in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

181% more capital invested

Capital invested by funds: $186M → $522M (+$336M)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

7% more funds holding

Funds holding: 27 → 29 (+2)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$781K
2
FIM
Freedom Investment Management
Connecticut
+$55.4K
3
JP Morgan Chase
JP Morgan Chase
New York
+$19K
4
Morgan Stanley
Morgan Stanley
New York
+$6.4K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$34.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SA
1
SAIF Advisors
Hong Kong
$405M – – –
O
2
OrbiMed
New York
$72M – – –
VC
3
Vivo Capital
California
$38.2M – – –
NAH
4
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
State Street
5
State Street
Massachusetts
$1.82M +$781K +120,765 +75%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.54M – – –
YMRC
7
Yorktown Management & Research Company
Virginia
$485K – – –
Skandinaviska Enskilda Banken (SEB)
8
Skandinaviska Enskilda Banken (SEB)
Sweden
$259K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
FIM
10
Freedom Investment Management
Connecticut
$117K +$55.4K +16,526 +90%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$106K – – –
Northern Trust
12
Northern Trust
Illinois
$55K -$34.3K -8,587 -38%
Group One Trading
13
Group One Trading
Illinois
$27K – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$19K +$19K +3,000 New
Morgan Stanley
15
Morgan Stanley
New York
$16K +$6.4K +1,000 +67%
HI
16
Harbour Investments
Wisconsin
$1K +$1K +180 New
FGAM
17
Financial Gravity Asset Management
Texas
$798 – – –

SVA Hedge Fund Activity: Q1 2021 in Review

29 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q1 2021, worth a combined $522M — up 181% from $186M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SVA positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was State Street, adding an estimated $781K. The largest seller was Northern Trust, cutting an estimated $34.3K.

  • 29 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q1 2021, up from 27 in Q4 2020.
  • Funds reported $522M of Sinovac Biotech, Ltd stock for Q1 2021, up 181% quarter-over-quarter.
  • 3 funds opened new Sinovac Biotech, Ltd positions in Q1 2021 and 1 closed out, a net change of +2 holders.
  • The largest Sinovac Biotech, Ltd buyer in Q1 2021 was State Street, an estimated $781K added.
  • The largest Sinovac Biotech, Ltd seller in Q1 2021 was Northern Trust, an estimated $34.3K sold.

Based on aggregated 13F filings for Q1 2021.